Immunodermatology News

Recent FDA actions have included approving Juvéderm Vollure XC for treating nasolabial folds with results up to 18 months and the addition of fingernail psoriasis data to Humira prescribing information.

ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Amy J. McMichael, MD, FAAD, discusses the Skin of Color Society.

The American Academy of Dermatology announced the results of its annual election, including Jane M. Grant-Kels, MD, FAAD, as vice president-elect and four new board members.

The American Academy of Dermatology announced that George J. Hruza, MD, MBA, FAAD, has been elected president-elect of the academy.

Patients with mild lupus had increased insulin resistance and hyperglucagonemia, while having normal glucose tolerance and a preserved beta-cell function and skeletal muscle GLUT-4 translocation, according to recently published data.

The FDA has granted breakthrough therapy designation status to Rituxan for treating pemphigus vulgaris, Genentech has announced.

ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, AAD President Henry W. Lim, MD, FAAD, outlines his vision for the academy in the upcoming year.

ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Seemal R. Desai, MD, FAAD, discusses highlights from the meeting’s Therapeutic Hotline session, which he directed.

ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Karen Edison, MD, FAAD, discusses the AAD’s SkinSerious campaign.

ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Henry W. Lim, MD, FAAD, discusses the economic burden of skin disease in the United States.